Correlation Between 23Andme Holding and Jasper Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Jasper Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Jasper Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Jasper Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Jasper Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Jasper Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Jasper Therapeutics.
Diversification Opportunities for 23Andme Holding and Jasper Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 23Andme and Jasper is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Jasper Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jasper Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Jasper Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jasper Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Jasper Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Jasper Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Jasper Therapeutics. In addition to that, 23Andme Holding is 2.22 times more volatile than Jasper Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Jasper Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest 2,203 in Jasper Therapeutics on September 5, 2024 and sell it today you would earn a total of 159.00 from holding Jasper Therapeutics or generate 7.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
23Andme Holding Co vs. Jasper Therapeutics
Performance |
Timeline |
23Andme Holding |
Jasper Therapeutics |
23Andme Holding and Jasper Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and Jasper Therapeutics
The main advantage of trading using opposite 23Andme Holding and Jasper Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Jasper Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will offset losses from the drop in Jasper Therapeutics' long position.23Andme Holding vs. Candel Therapeutics | 23Andme Holding vs. Cingulate Warrants | 23Andme Holding vs. Unicycive Therapeutics | 23Andme Holding vs. Cardio Diagnostics Holdings |
Jasper Therapeutics vs. Lyra Therapeutics | Jasper Therapeutics vs. Equillium | Jasper Therapeutics vs. Hookipa Pharma | Jasper Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |